NWA Oncologist Authors Research on Breast Cancer Treatment

Fayetteville, AR, December 16, 2015 (Newswire.com) - Dr. J Thaddeus Beck, of Highlands Oncology Group (HOG), Northwest Arkansas’ premier cancer treatment facility, authored research which has been published by Dove Medical Press. The research, entitled “potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer,” focuses on potential treatment options for advanced breast cancer patients. 

The article studies the effects of a targeted medley of treatment therapies with the goal of maintaining greater anti-tumor effects and also delaying or reversing treatment resistance.

Breast cancer is the most common cancer among American women besides skin cancers. About 231,840 new cases of invasive breast cancer will be diagnosed in women in the United States in 2015, according to American Cancer Society estimates.

In 2015, there are more than 2.8 million women with a history of breast cancer in the U.S., according to breastcancer.org, a non-profit organization dedicated to breast cancer awareness. This includes women currently being treated and women who have finished treatment.

Dove Medical Press is a company located in the United Kingdom which specializes in the publication of peer-reviewed journals across the broad spectrum of science, technology and medicine, according to their website.

As the leading cancer treatment and research facility in Northwest Arkansas, HOG is dedicated to the advancement of cancer treatment and to providing patients with the best possible care and results.

To learn more about this research visit: https://www.dovepress.com/articles.php?article_id=24879

###

Highlands Oncology Group is a state-of-the-art facility, with a world-class team of specialists, that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved ones. Highlands Oncology group provides this in a friendly, comfortable environment conveniently located in Northwest Arkansas. Highlands offers the latest technology of diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer every day.

For more information visit www.HighlandsOncologyGroup.com.